Rob ter Heine

Quantification of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography–triple quadrupole mass spectrometry

Rob ter Heine, Hilde Rosing, E.C.M. van Gorp et al. · Journal of Chromatography B · 2008 · 114 citations

Protease Inhibitors, Proteomic Technology, Biochemistry +13

Model‐Informed Precision Dosing at the Bedside: Scientific Challenges and Opportunities

Ron J. Keizer, Rob ter Heine, Adam Frymoyer et al. · CPT Pharmacometrics & Systems Pharmacology · 2018 · 114 citations · Full text

Precision Dosing, Model-informed Precision Dosing, Translational Medicine +13

Efficacy of BCG Vaccination Against Respiratory Tract Infections in Older Adults During the Coronavirus Disease 2019 Pandemic

Simone J.C.F.M. Moorlag, Esther Taks, Thijs ten Doesschate et al. · Clinical Infectious Diseases · 2022 · 91 citations · Full text

Fast and simultaneous determination of darunavir and eleven other antiretroviral drugs for therapeutic drug monitoring: method development and validation for the determination of all currently approved HIV protease inhibitors and non‐nucleoside reverse transcriptase inhibitors in human plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry

Rob ter Heine, Carolien G. Alderden‐Los, Hilde Rosing et al. · Rapid Communications in Mass Spectrometry · 2007 · 84 citations

Coadministration of Ritonavir Strongly Enhances the Apparent Oral Bioavailability of Docetaxel in Patients with Solid Tumors

Roos L. Oostendorp, Alwin D. R. Huitema, Hilde Rosing et al. · Clinical Cancer Research · 2009 · 78 citations